Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Akero Therapeutics, Inc. (AKRO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Akero Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Akero Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is AKRO. The reporting company's CIK number is 1744659.
The total value of stock buying since 2005 is $51,840,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-06-24||Atlas Venture Opportunity Fund I, L.p. (10% Owner)||Buy||270,000||16.00||4,320,000|
|2019-06-24||Royston Aaron (Director)||Buy||250,000||16.00||4,000,000|
|2019-06-24||Versant Venture Capital Vi, L.p. (10% Owner)||Buy||400,000||16.00||6,400,000|
|2019-06-24||Atp Iii Gp, Ltd. (10% Owner)||Buy||900,000||16.00||14,400,000|
|2019-06-24||Bitterman Kevin (Director)||Buy||270,000||16.00||4,320,000|
|2019-06-24||Harrison Seth Loring (Director)||Buy||900,000||16.00||14,400,000|
|2019-06-24||Goodman Corey S (10% Owner)||Buy||250,000||16.00||4,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of AKRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Akero Therapeutics, Inc. (symbol AKRO, CIK number 1744659) see the Securities and Exchange Commission (SEC) website.